| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |